Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
Showing 381 - 400 results of 2,087 for search '(( significantly reported decrease ) OR ( significant decrease decrease ))~', query time: 0.25s Refine Results
  1. 381
    S1 File -

    S1 File - by Valérie Chetboul (579758)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 382
    Number of Doppler examinations (i.e., 1, 2, or 3) that allowed the board-certified specialist (VC) in charge of the French cardiovascular breed screening program (2010–2023) to conclude to a definitive cardiac status regarding aortic stenosis (AS) and pulmonic stenosis (PS) (n = 876 for AS and n = 879 for PS out of the 921 Newfoundland dogs that underwent the screening program).

    Number of Doppler examinations (i.e., 1, 2, or 3) that allowed the board-certified specialist (VC) in charge of the French cardiovascular breed screening program (2010–2023) to con... by Valérie Chetboul (579758)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 383
    Growth of Sf14 in various media.

    Growth of Sf14 in various media. by Nykki D. Ross (20933968)

    Published 2025
    Save to List
    Saved in:
  4. 384
    Growth of Sf14 in various media and temperatures.

    Growth of Sf14 in various media and temperatures. by Nykki D. Ross (20933968)

    Published 2025
    Save to List
    Saved in:
  5. 385
    Growth of bacteria in various media and temperatures with or without Sf14 infection.

    Growth of bacteria in various media and temperatures with or without Sf14 infection. by Nykki D. Ross (20933968)

    Published 2025
    Save to List
    Saved in:
  6. 386
    Growth of bacteria in various media and temperatures with or without Sf14 infection.

    Growth of bacteria in various media and temperatures with or without Sf14 infection. by Nykki D. Ross (20933968)

    Published 2025
    Save to List
    Saved in:
  7. 387
    Flow Chart of Study Participant Selection.

    Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

    Published 2025
    “…Notably, individuals with long sleep duration (>9 hours) had a significantly decreased risk of CVD (OR: 0.36, 95% CI: 0.15–0.85, P = 0.02) compared to those with shorter sleep durations.…”
    Save to List
    Saved in:
  8. 388
    Innovation and night light in large and small cities.

    Innovation and night light in large and small cities. by Saul Estrin (8629173)

    Published 2024
    Save to List
    Saved in:
  9. 389
    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Quite encouragingly, the incorporation of Au<sup>3+</sup> facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …”
    Save to List
    Saved in:
  10. 390
    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Quite encouragingly, the incorporation of Au<sup>3+</sup> facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …”
    Save to List
    Saved in:
  11. 391
    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Quite encouragingly, the incorporation of Au<sup>3+</sup> facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …”
    Save to List
    Saved in:
  12. 392
    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance

    Colored Gold Ions Enabled High-Transparent and Low-Haze Cellulose Films with Excellent Flame-Retardant and UV to Blue Light-Blocking Performance by Qiu Fu (10830823)

    Published 2025
    “…Quite encouragingly, the incorporation of Au<sup>3+</sup> facilitates films in achieving desirable flame retardancy, evidenced by a significant increase in the limiting oxygen index from 19.2% to 39.2%. …”
    Save to List
    Saved in:
  13. 393
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 394
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  15. 395
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 396
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 397
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 398
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 399
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 400
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: